Contact Info

Social Links

News & Updates

Statement on the Merck Voluntary License on Alimatravir and Unitaid’s Announced Support For African Licensees

Unitaid welcomes African manufacturing investment for alimatravir but urges Merck to expand its 129-...

Read More

Communities Delegation at the 50th Executive Board of Unitaid

Communities Delegation at Unitaid's 50th Board meeting in Paris, July 2026: advocating for community...

Read More

Curable, but still out of reach: why hepatitis C demands a harm reduction response

Advocate Anton Basenko shares his journey with drug use, HIV and hepatitis C, and makes the case for...

Read More

South Africa launches bid to enable local production of long-acting HIV prevention drug, lenacapavir

South Africa launches an initiative to enable local production of lenacapavir, a long-acting HIV pre...

Read More

Accelerating Cervical Cancer Elimination: Unitaid Launches New Funding Opportunity

Unitaid is inviting proposals to accelerate cervical cancer elimination through secondary prevention...

Read More

Reaching communities in Sierra Leone with TB prevention

In Sierra Leone, Unitaid’s IMPAACT4TB project is expanding access to short, effective TB prevention,...

Read More

Communities Delegation at the 48th Executive Board of Unitaid

Communities Delegation members actively engaged in Unitaid’s EB48 meeting in Tokyo, advocating for s...

Read More

Delegação das Comunidades na 48ª Reunião do Conselho Executivo da Unitaid

Delegação das Comunidades na EB48 Unitaid (Tóquio, Dez 2025): Aprovada CCSE com pilotos (Lenacapavir...

Read More

Délégation des Communautés auprès du 48e Conseil d’administration d’Unitaid

Délégation des Communautés à l’EB48 Unitaid (Tokyo, déc. 2025) : Approbation CCSE avec pilotes (Lena...

Read More